Join
Live feed
·
INSIDERFilingvia Quantisnow
Liminatus Pharma Inc. logo

Large owner Valetudo Therapeutics Llc acquired 3,448,926 shares, increasing direct ownership by 192% to 5,244,351 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LIMN· Liminatus Pharma Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIMN (Liminatus Pharma Inc.) and more on Quantisnow.